Cumberland Pharmaceuticals CPIX Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's pre-tax income?
- Cumberland Pharmaceuticals (CPIX) reported pre-tax income of -$3.14M in Q1 2026.
- How has Cumberland Pharmaceuticals's pre-tax income changed year-over-year?
- Cumberland Pharmaceuticals's pre-tax income decreased by 350.2% year-over-year, from $1.25M to -$3.14M.
- What is the long-term trend for Cumberland Pharmaceuticals's pre-tax income?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's pre-tax income has grown at a -15.7% compound annual growth rate (CAGR), from -$5.56M to -$2.81M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.